1. All Products
  2. DORA - Oral drugs
  3. COTRIMOXAZOLE, 100mg/ 20mg, disp. tab.
Public Pricelist

COTRIMOXAZOLE, 100mg/ 20mg, disp. tab.

https://medicalguidelines.msf.org/en/node/387
https://unicat.msf.org/cat/product/64979
STD DORACOTR1TD

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
6.5.4 - Antipneumocystosis and antitoxoplasmosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01EE01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

COTRIMOXAZOLE (CTX)

Therapeutic Action

Combination of two antibacterials: a sulfonamide (sulfamethoxazole) and a diaminopyrimidine antifolate (trimethoprim)

Indications

Cerebral toxoplasmosis, pneumocystosis, isosporiasis, cyclosporiasis and brucellosis

Prophylaxis of pneumocystosis, toxoplasmosis and isosporiasis

Second-line treatment of pertussis

Typhoid fever if the strain is susceptible

Instructions for use

The dispersible tablet is intended for paediatric use. It replaces the oral suspension and the 120 mg normal tablet.

Precautions for Use

Do not administer to children under 1 month of age.

Storage

Below 25°C - Protect from sunlight - Protect from humidity